The New, Impending Adult ADHD Guidelines

Listen

0:00 / 0:00

Key Takeaways

APSARD is preparing the first US-focused adult ADHD guideline set to address diagnostic uncertainty and treatment variability in everyday practice.
Recommendations are expected to span structured screening, differential diagnosis, and evidence-based pharmacologic and nonpharmacologic interventions tailored to adult functional impairments.
Leadership commentary from APSARD president Brooke Molina, PhD, signals imminent publication and offers early insight into scope and intent.
Industry-facing psychiatric media channels plan ongoing coverage to support clinician adoption and keep stakeholders current as guidance is released.

APSARD is preparing US adult ADHD guidelines, delivering long-awaited screening, diagnosis, and treatment recommendations as experts discuss the upcoming release.

We know attention-deficit/hyperactivity disorder (ADHD) persists beyond childhood and into adulthood, but we lack any existing guidelines in the United States for the diagnosis and treatment of adult ADHD. A solution to this problem is coming.

The American Professional Society of ADHD and Related Disorders (APSARD) recently shared that its US Adult ADHD Guidelines are almost ready to launch. These guidelines are intended to provide comprehensive recommendations for the screening, diagnosis, and treatment of ADHD in adults. Psychiatric Times, always at the forefront of breaking psychiatric news, recently spoke to APSARD president Brooke Molina, PhD, about their impending release.¹ I highly encourage you to check out our interview.

We are committed, as always, to keeping you informed about the latest updates in psychiatric practice. Thank you for placing your trust in us for more than 4 decades.

Mike Hennessy Jr

Chairman and CEO, MJH Life Sciences

Reference

1. Kuntz L, Molina B. Insights on the new adult ADHD guidelines: a conversation with the president of APSARD. Psychiatric Times. September 15, 2026. https://www.psychiatrictimes.com/view/insights-on-the-new-adult-adhd-guidelines-a-conversation-with-the-president-of-apsard

Articles in this issue

3 days ago

Article

Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression

4 days ago

Article

Measurement-Informed Psychiatric Care: If Not Now, Then When?

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

The New, Impending Adult ADHD Guidelines

Key Takeaways

Articles in this issue

Related to this article

Trending on Psychiatric Times

Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia

Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression

Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics

Measurement-Informed Psychiatric Care: If Not Now, Then When?

Blood-Based Biomarkers for Alzheimer Disease: Accuracy, Limits, and Confounders